Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by donkeyfeatherson Jan 03, 2021 5:43pm
262 Views
Post# 32212395

RE:RE:RE:RE:RE:Nice gains

RE:RE:RE:RE:RE:Nice gains

Hey Red,

14 years ago this company had a Sertoli bath and that wasn’t enough.  All the sweat and toil since, it’s looking more and more like we have an answer to that protective environment question confirmed.  This is where John W. and I agreed - what an accomplishment to build and patent that protection.  Now…14 years later, will current management monetize all that foresight and insight?  Based on what others are paying for pieces of a protection solution (that are years behind SVA if they are to put all the pieces together), can the board sell this for what it's worth?  In my case that is the $1-2 million question, and has me keenly waiting for the Witkowski news too.
DF

<< Previous
Bullboard Posts
Next >>